SOHM, Inc. Announce Interim Shareholder update
Chino Hills, CA – September 11, 2020 – SOHM, Inc. (Pink Sheets: SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today some of the developments with the company and their re-entry into the US OTC retail, prescription, contract manufacturing, and white label manufacturing and marketing space.
Mr. Baron Night-CEO announced today that the company has continued with the development and introduction of 5 new products into its product line while maintaining consistency with the company’s outlook and strategic plan. All manufacturing is in the USA. Our products are currently being marketed and sold in the USA.
1. Nail Renovar-Nail Fungus treatment. This global market is projected to reach 6.7 Billion by 2026.
2. Hand Sanitizer Spray with Aloe Vera- Personal Care
3. Anti-Microbial Multi-Purpose Spray- Personal Care
4. Anti-Microbial Hand Soap- Personal Care and
5. Non-Alcoholic Hand Sanitizer Gel-Personal Care
SOHM will be introducing some additional new products in-line with its Globalè Prospèro Vision 2024 in the coming weeks/months.
The company is still working and generating revenues with its B2B private label prescription product customers in conjunction with its Business to Consumer segments.
The current pandemic has impacted everyone. We have taken steps to balance health concerns with revenues. Mr. Night informed.
Mr. Night-CEO has further stated that the company management has no plans to conduct any reverse split of shares as announced in January of 2018.
The company has not issued any shares to anyone including promoters, officers, directors, and/or employees in the last several years. SOHM also has not retired any financial notes through the issuance of any shares in the year 2019 and to date during the current year. The company issued totaling approx. 27.7 million shares restricted shares in the fourth quarter of 2019 and the second quarter of 2020 for attorney services.
The company and management will honor all previously announced commitments made to all stakeholders.; Mr. Night added.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision “Globalè Prospèro” that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as a strategic alliance with US manufacturing facilities. Although SOHM’s generic pharmaceuticals were exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
Safe Harbor Statement:
This news release contains “forward-looking statements”, which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.
For more information, please contact:
SOHM, Inc.
714-522-6700